LifeMD Investors Reminded of Class Action Lawsuit

Strategic Insights -

Pursuant to a class action lawsuit, shareholders who purchased shares of LifeMD (NASDAQ: LFMD) between May 7, 2025, and August 5, 2025, are encouraged to contact DJS Law Group regarding possible lead plaintiff appointments. The lawsuit alleges that LifeMD made false and misleading statements to the market, ignoring important factors such as customer acquisition costs, which led to an inflated public guidance for fiscal year 2025. If you are a shareholder who suffered a loss, you may be eligible to participate in the case and potentially recover your losses.

Key Takeaways:

  • LifeMD investors who purchased shares between May 7, 2025, and August 5, 2025, may be eligible to participate in a class action lawsuit.
  • The lawsuit alleges that LifeMD made false and misleading statements to the market, leading to an inflated public guidance for fiscal year 2025.
  • The company ignored important factors such as customer acquisition costs.
  • Shareholders who suffered a loss may be eligible to recover their losses through participation in the lawsuit.
  • DJS Law Group is advocating on behalf of investors in the class action lawsuit.
  • The primary focus of DJS Law Group is to enhance investor return through balanced counseling and aggressive advocacy.
  • The firm specializes in securities class actions, corporate governance litigation, and domestic/international M&A appraisals.

Statistics:

  • Class Period: May 7, 2025 to August 5, 2025
  • Deadline for Lead Plaintiff Appointment: October 27, 2025
  • Number of Days to Register: 7 days following the publication of this press release
  • Expected Number of Affected Investors: Not specified
  • Potential Recovery: Not specified

Sources:

  • "Class Action Lawsuit Reminds Investors of Securities Fraud Litigation Against LifeMD, Incorporated (NASDAQ: LFMD)" - PRNewswire (Oct. 20, 2025)
  • DJS Law Group LLP
  • "Securities Class Action Litigation" - DJS Law Group LLP